RNXT · ISSUER CIK 1574094
RenovoRx, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 RenovoRx, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202606:04 | Sep 10, 2026 | RNXT | Chief Financial Officer | A · GrantLate 5d | — | +80,000 | 222,380 | +56% | — |